

Trailing twelve months is not an accounting detail; it is the lens buyers use to test earnings quality and momentum. A business can look strong on annual reports and still fail diligence if the recent run-rate has softened, been smoothed, or depends on one-off wins. Founders who understand how buyers read TTM can protect valuation before the first offer is ever made.
Your last full fiscal year showed $1.2M in EBITDA. You've priced the business accordingly. The buyer's advisor pulls trailing twelve months — and the most recent six are running 22% below the comparable period. That gap doesn't get explained away in a management presentation. It gets priced.
Buyers don't anchor to your best year or your average year. They anchor to right now. The trailing twelve months is the buyer's working hypothesis about what the business will earn after they own it. Everything else is context.
Most founders treat TTM as a reporting convention — a number their accountant calculates somewhere in the data room. Buyers treat it as a diligence test. They're asking: is the performance I'm paying for still happening?
If your most recent months don't support your asking price, the multiple compresses. Not always dramatically, but enough to matter. A 0.5x reduction on a $1.2M EBITDA business at a 4x multiple is $240,000 off the table — before any other adjustments.
When a buyer calculates TTM, they're not running a historical exercise. They're building their best estimate of what the business earns today — the baseline they'll use to justify the acquisition price to their investors, their lender, or their own board.
A three-year average tells them what the business has done. TTM tells them whether those earnings are still happening. Those are different questions with different implications for price and deal structure.
Buyers underwrite the present, not the past — and TTM is the closest proxy they have for it.
TTM means the most recent 12 consecutive months of financial performance, regardless of where they fall in the calendar year. If you're selling in October, TTM runs from November of the prior year through October of the current one. It doesn't align with your fiscal year. That misalignment is often where problems surface.
Buyers use TTM because it's the most current picture available. A fiscal year ending December 31 might already be nine months stale by the time a deal gets to diligence. A lot can change in nine months — client mix, project volume, margin profile.
The standard calculation takes your most recent full fiscal year and adjusts it: add the current year-to-date figures, subtract the same period from the prior year. The result is a rolling 12-month view that moves with the calendar.
Buyers also normalize TTM for one-time items, owner compensation above market rate, and non-recurring expenses — the same adjustments that appear in a quality of earnings report. The TTM EBITDA they build is adjusted, not raw.
If your business had a strong Q4 last year but a weak Q1 and Q2 this year, TTM will capture all three. Your annual P&L for the prior year looked clean. TTM tells a different story — one where recent softness is visible and weighted.
The period a buyer selects for TTM isn't arbitrary — it's chosen to reflect the most current earnings trajectory available.
A full-year P&L smooths performance across twelve months. A strong first half offsets a weak second half. The total looks acceptable. Buyers know this, which is why they don't stop at annual totals — they sequence the months.
When buyers look at monthly revenue and EBITDA across the trailing period, they're watching for direction. Is the business accelerating, flat, or decelerating? A declining second half inside a positive annual number is a red flag, not a reassurance.
A strong annual P&L can hide a recent slowdown — and buyers will weight the most recent months heavily when deciding whether performance is holding.
Annual financials are built for tax reporting, banking covenants, and internal planning. They're not built to answer the question a buyer is actually asking: is this business performing at the level I'm being asked to pay for, right now?
The problem isn't that annual financials are inaccurate. It's that they aggregate in ways that conceal momentum. A business that earned $900K EBITDA in the first six months and $300K in the second six months shows $1.2M for the year. That looks identical to a business that earned $600K in each half. The multiples applied to those two businesses should not be the same.
When you present annual numbers, you're presenting a sum. When buyers sequence those same numbers month by month, they see a story — one you may not have intended to tell. The sequencing reveals whether your business is building or contracting.
Founders who rely on annual totals going into a sale process often get surprised in diligence. Not because they misrepresented anything, but because the granular view the buyer builds contradicts the headline narrative.
Most founders remember their best year. They use it as the anchor for valuation conversations, as the proof point in their investor memo, as the number they lead with. Buyers remember the most recent months. Those two reference points are frequently in tension.
If the most recent TTM is below that best year by more than 10–15%, expect the buyer to challenge the multiple. The question they're asking themselves is: am I paying for the past or for what I'm actually going to own?
Deferred projects, pulled-forward revenue, and catch-up billing can all create the appearance of strong performance in a given period. A large project invoiced in Q4 that should have landed in Q1 moves the annual number without changing the underlying run rate.
Buyers who are doing rigorous diligence will ask for project-level revenue schedules, billing milestones, and backlog reports. They're trying to determine whether TTM revenue reflects real demand or accounting timing.
If your recent revenue is front-loaded or project-dependent, expect buyers to recast TTM to exclude what they consider non-recurring — and watch the EBITDA number shift.
TTM isn't just a number buyers calculate. It's a lens they run multiple tests through. Each test is designed to answer a different question about whether the earnings you're presenting are real, repeatable, and transferable.
Buyers want to know whether TTM revenue comes from sources that will still be there after the acquisition. Retainer contracts, recurring engagements, and long-term client relationships read differently than one-time projects, even if both generate the same dollar amount in the period.
A TTM period dominated by large, non-recurring engagements signals revenue concentration risk and questions about forward pipeline. Buyers will adjust their view of normalized earnings accordingly.
If gross margin in the most recent three months of TTM is lower than gross margin in the first nine months, buyers notice. That trend implies cost pressure, pricing erosion, or scope creep that isn't being recovered. A declining margin within a stable revenue line is often more concerning than a revenue dip.
The margin trend question is direct: is the business becoming more or less efficient over time? TTM gives buyers enough data to form a view.
Buyers also look at whether TTM performance is being sustained by founder involvement that won't transfer. If revenue in the most recent months is heavily tied to the founder's direct client relationships, technical delivery, or business development, the buyer mentally adjusts the earnings downward to account for replacement cost.
Clean, repeatable, margin-stable TTM earnings give buyers a reason to defend a higher multiple to their own stakeholders.
Many service businesses have genuine seasonal patterns — Q1 is slow, Q4 is strong, summer contracts thin out. Founders often treat this as background context. Buyers treat it as a structural question about earnings reliability.
If your TTM captures a disproportionately strong quarter and a buyer is pricing the deal in a weak season, they'll want to see enough historical periods to know whether the seasonality is consistent or worsening. One strong quarter inside TTM doesn't neutralize three weaker ones.
Seasonality matters more than many founders expect — buyers want to know whether the business is consistently profitable or only appears that way in certain quarters.
Weak recent months are the single most common reason buyers reduce their initial offer or restructure deal terms toward earnouts and seller financing. The signal they send is straightforward: the business may be declining, and the buyer is being asked to absorb that risk at a price set before the decline was visible.
Buyers don't assume the worst automatically. But they do require an explanation — and that explanation needs to be specific, documented, and plausible within the context of the business model.
Project delays with documented email trails, a major client pausing scope during their own internal reorganization, a seasonal dip consistent with two prior years — these explanations hold up in diligence because they're verifiable and cyclical rather than structural.
Buyers can underwrite recoverable dips. They can't underwrite ambiguity. If the explanation for weak recent months is vague — the market softened, we had some turnover, we lost a key person — the buyer will assume the worst-case interpretation and price accordingly.
If weak recent months coincide with a key client departure, a pricing change, or a shift in service delivery model, that's a structural signal. Buyers won't treat it as noise. They'll want to understand whether the business has permanently lost something it previously counted on.
The worst position to be in is having weak months you can't explain confidently. That gap — between performance and narrative — is where buyer confidence erodes fastest.
If the latest months are weaker than the prior year, the market will notice — and that gap can reduce confidence in the multiple even when total EBITDA looks acceptable.
A buyer who sees declining recent performance doesn't always walk away. Sometimes they restructure the deal instead — shifting more consideration into an earnout, requesting a seller note, or reducing the cash-at-close component. These mechanics transfer risk back to the seller.
The practical effect: a business with $1.2M TTM EBITDA but declining recent months might close at 3.5x versus 4.5x on the headline — a $1.2M difference in total consideration. Or the 4.5x gets preserved on paper but 25% of it moves into an earnout tied to forward performance.
Weak recent months don't just reduce the multiple — they change the deal structure, and structure determines how much of the headline number you actually receive at close.
Timing distortions in TTM are common, often legitimate, and almost always misread by buyers without context. The problem isn't that your financials are inaccurate — it's that the timing of revenue recognition can make a normal business look like it's spiking or declining when it's neither.
If a client prepaid an annual retainer in January of the current year but the comparable payment landed in March last year, your January TTM looks strong relative to prior January. That's not growth — it's a timing shift. Buyers will find it. If you don't explain it proactively, they'll interpret it as a revenue concentration event and question the repeatability.
Project-based service businesses often defer revenue recognition until milestones are met. If three large projects hit completion simultaneously in one quarter, TTM for that period looks exceptional. The following quarter looks weak by comparison — even if the pipeline is identical.
Buyers will sequence your quarterly revenue carefully. An abnormal spike followed by a trough, even within a single TTM window, raises questions about whether the run rate is sustainable or whether you're living on project timing.
The reverse applies to costs. If you deferred a major hire, pushed capital expenditures, or delayed a software renewal to keep margins clean during the sale process, buyers who review expense trends will see the gap. Artificially clean margins in a TTM period are a red flag, not a selling point.
Timing distortions are manageable when disclosed — they become valuation problems when buyers discover them independently during diligence.
Beyond weak months, there are specific patterns within TTM that trigger systematic skepticism. Revenue concentrated in the last two months of the period — which may not recur — is one. Another is a margin profile that looks stable in aggregate but is declining sequentially when buyers run the monthly trend.
Buyers also flag sharp changes in client composition within the TTM window: new clients generating a disproportionate share of recent revenue, or legacy clients who account for a smaller percentage than they did a year ago. Both raise questions about relationship durability and forward revenue stability.
Clean TTM reporting can support a higher valuation narrative — messy reporting forces buyers to discount for uncertainty and diligence friction.
There are patterns in TTM that buyers treat as automatic caution signals — not deal-killers by default, but triggers for deeper scrutiny and valuation conservatism. Understanding them before you go to market gives you time to address or contextualize them.
If 40% of your TTM revenue came from one client in the most recent quarter, that's a concentration problem and a timing problem simultaneously. Buyers will ask what happens to earnings if that client reduces scope or doesn't renew. They won't accept a confident answer without documentation of the relationship history and contract terms.
A business that was 60% retainer-based two years ago but is now 40% retainer-based shows a structural shift in revenue quality within the TTM window. Even if total revenue is flat or growing, the shift away from recurring sources signals higher earnings volatility going forward.
If EBITDA margin is declining within TTM — say, from 28% in months one through six to 21% in months seven through twelve — buyers will probe every cost line. Unexplained margin compression inside a stable revenue period suggests pricing pressure, scope creep, or cost structure problems that haven't yet been addressed.
Key person departures, unexpected senior hires, or a spike in subcontractor costs within TTM all raise structural questions. Buyers want to understand whether the delivery model changed and whether TTM earnings reflect the business as it will operate post-acquisition.
Every red flag in TTM that you can explain clearly before diligence is one less reason for a buyer to restructure the deal in their favor.
The distinction between historical EBITDA and forward run rate is where most valuation disagreements in service business deals actually live. A founder sees three years of strong performance. A buyer sees the most recent six months and builds a run rate from there.
If you want to be paid on a multiple of trailing performance, the trailing performance needs to be consistent with the run rate a buyer can defend to their own stakeholders. That requires the most recent months to be your strongest argument, not your weakest.
Founders should manage the business toward a defensible run rate long before they go to market — the last 12 months often determine the price, not the best 12 months.
The goal isn't to manipulate TTM — it's to understand it well enough that you can present it in context, anticipate every question a buyer will ask, and eliminate the ambiguity that forces buyers to assume the worst.
Start by building your own TTM analysis before you engage a buyer. Run the calculation yourself, sequence the months, identify the anomalies, and write the narrative for each one. If you can't explain a variance clearly in two sentences, a buyer's advisor won't accept a vague answer in diligence either.
Work with your advisor to normalize TTM EBITDA the same way a quality of earnings process will. Remove one-time items, adjust owner compensation, add back legitimate non-recurring expenses with documentation. The normalized TTM you present should hold up to third-party scrutiny — because it will receive it.